Cubist Systematic Strategies, LLC Staar Surgical CO Call Options Transaction History

Cubist Systematic Strategies, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$29.97 - $47.42 $218,781 - $346,166	7,300 Added 54.48%	20,700 $769,000
Q2 2024 Aug 14, 2024	SELL	$38.07 - $52.25 $1.38 Million - $1.9 Million	-36,300 Reduced 73.04%	13,400 $637,000
Q1 2024 May 15, 2024	SELL	$27.67 - $39.61 $572,769 - $819,927	-20,700 Reduced 29.4%	49,700 $1.9 Million
Q4 2023 Feb 14, 2024	BUY	$30.6 - $43.78 $1.08 Million - $1.55 Million	35,300 Added 100.57%	70,400 $2.2 Million
Q3 2023 Nov 14, 2023	BUY	$39.39 - $58.12 $1.02 Million - $1.51 Million	26,000 Added 285.71%	35,100 $1.41 Million
Q2 2023 Aug 14, 2023	SELL	$50.45 - $72.82 $10,090 - $14,563	-200 Reduced 2.15%	9,100 $478,000
Q1 2023 May 15, 2023	BUY	$51.25 - $79.34 $476,625 - $737,862	9,300 New	9,300 $594,000

255

47.8M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.35B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.